Health Care [ 6/12 ] | Biotechnology [ 32/73 ]
NASDAQ | Common Stock
Ikena Oncology, Inc., an oncology company, focuses on developing therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance.
It develops IK-595, a molecular glue designed to trap MEK and RAF in an inactive complex.
The company was incorporated in 2016 and is headquartered in Boston, Massachusetts.
As of July 25, 2025, Ikena Oncology, Inc. was acquired by Inmagene Biopharmaceuticals Co. Ltd.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Jun 6, 25 | -0.15 Increased by +54.88% | -0.41 Increased by +63.68% |
| Mar 10, 25 | -0.18 Increased by +61.28% | -0.17 Decreased by -7.06% |
| Nov 7, 24 | -0.21 Increased by +47.50% | -0.27 Increased by +22.22% |
| Aug 8, 24 | -0.28 Increased by +36.36% | -0.35 Increased by +20.00% |
| May 13, 24 | -0.33 Increased by +15.38% | -0.41 Increased by +19.51% |
| Mar 12, 24 | -0.47 Decreased by -17.50% | -0.43 Decreased by -9.30% |
| Nov 9, 23 | -0.40 Increased by +16.67% | -0.43 Increased by +6.98% |
| Aug 10, 23 | -0.44 Increased by +22.81% | -0.47 Increased by +6.38% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 30, 25 | 0.00 Decreased by N/A% | -2.77 M Increased by +79.85% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 25 | 0.00 Decreased by N/A% | -8.62 M Increased by +46.62% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 24 | 0.00 Decreased by -100.00% | -9.12 M Increased by +53.18% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 24 | 0.00 Decreased by -100.00% | -10.23 M Increased by +40.99% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by -100.00% | -13.73 M Increased by +19.78% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 24 | 0.00 Decreased by -100.00% | -16.15 M Decreased by -13.55% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 23 | 659.00 K Decreased by -87.91% | -19.49 M Decreased by -49.00% | Decreased by -2.96 K% Decreased by -1.13 K% |
| Sep 30, 23 | 1.19 M Decreased by -81.49% | -17.34 M Decreased by -3.23% | Decreased by -1.46 K% Decreased by -457.71% |